Maternal Fetal Medicine
Welcome to the Division of Maternal-Fetal Medicine
The MFM Division is currently composed of five full-time MFM members, two hospitalists, one clinical research director, and one laboratory PhD director. The faculty physicians provide inpatient and outpatient consultation as well as primary comprehensive care of high-risk pregnancies, fetal ultrasound, prenatal diagnosis and invasive fetal treatment. We are affiliated with Indiana University Hospital and Riley Children's Hospital, one of the top children's hospitals in the United States.
The Maternal-Fetal Physician group operates as an integrated group serving referring providers at four IU Health Hospitals throughout the Indianapolis metropolitan area and the Wishard Memorial Hospital on campus. The combined annual deliveries for the integrated system exceed 7,000. The IU MFM group and the Level 3 NICU at Riley also serve as the tertiary care referral expansion of the Division to 11 MFM physicians in order to provide outpatient consultative services at several other hospitals in central Indiana.
Our TeamMen-Jean Lee, MD Division DirectorFrank Schubert, MDChristian Littion, MDRenata Sawyer, MDBarrett Robinson, MD, MPH
Kristine Stone, MS, Genetic CounselorKarrie Hines-Theoharis, MS PhD, Genetic CounselorMeredith Pastrick, MS, Genetic Counselor
Sandra Jenkinson, MS, Genetic Counselor
David M. Haas, MD, Director of Clinical ResearchJill M. Reiter, PhD, Director, OB Perinatal Epigenetics Research LabSara K. Quinney, PharmD, PhD, Assistant Scientist, Collaborator, Center for Pharmacogenetics and Therapeutic Research
Our Clinical Strengths and Expertise
The Division offers a full range of diagnostic and treatment options for the women of Indiana. Some of the services include:
Management of the Diabetic Pregnancy
The Maternal-Fetal Medicine specialists manage more diabetic pregnancies than any other physician group in the state of Indiana. Our physicians are highly skilled at working with diabetic patients to ensure that they have the healthiest possible pregnancy and baby.
Management of the High Risk Pregnancy
Our Maternal-Fetal Medicine physicians are well trained to manage many types of high-risk pregnancies. They manage and deliver more high-risk pregnancies than any other group of physicians in the state of Indiana.
Our Maternal-Fetal Medicine doctors use and advanced, highly sensitive, ultrasound that will allow them to detect certain birth defects. You may be referred to one of our high-risk obstetricians for a High-Resolution Ultrasound if your primary Ob/Gyn physician believes that a specialist would be better able to evaluate and manage your pregnancy.
Amniocentesis is a procedure in which a small sample of amniotic fluid (the fluid surrounding your baby) is withdrawn from the uterus using a fine needle that is guided by ultrasound. The fluid contains cells from the baby that can be analyzed to detect a variety of genetic problems. Amniotic fluid contains Alpha-Fetoprotein (AFP), and the analysis of AFP allows physicians to screen for neural tube defects, ventral wall defects, and high-risk pregnancies.
Chorionic Villi Sampling (CVS)
CVS is a relatively new diagnostic test used early in a woman's pregnancy. With CVS, the doctor will remove a small amount of the villi (tissue that will eventually become the placenta) from your womb. The villi will be analyzed to screen for certain chromosomal or genetic problems that can be diagnosed in your baby. The doctor will use a fine needle to obtain the villi, and the needle will either be inserted into your abdomen or vagina to access the womb.
Maternal Serum Alpha-Fetoprotein (MS-AFP) Testing and Follow-up Services
Most general obstetricians order and AFP test in the early pertion of a woman's pregnancy. If the AFP test demonstrates that you have elevated AFP levels, it may indicate that your baby has certain birth defects. At IU Women's Healthcare, our high-risk obstetricians will work with your primary Ob/Gyn to analyze your AFP test and recommend additional tests that will help to determine the health of your baby.
Percutaneous Umbilical Blood Sampling (PUBS)
PUBS is a very new diagnostic test during which the doctor will remove a small amount of blood from the umbilical cord of your baby. A wide variety of diagnostic tests can be performed using the umbilical cord of your baby. A wide variety of diagnostic tests can be performed using the umbilical cord blood sample. PUBS may also be used if your baby requires a blood transfusion while he/she is still in your uterus. Using an ultrasound machine and a fine needle, the doctor can transfuse your baby's umbilical cord with blood if it is needed.
First Trimester freeBeta/PAPP-A/NT Testing
This test is available to women during their first trimester of pregnancy (10 weeks 4 days - 13 weeks 3 days), and it used to help identify babies who may be at risk for Down syndrome or Trisomy 18. The test involves both blood testing ans a special ultrasound exam to help determine your baby's risk for birth defects.
Preconceptual and Genetic Counseling
Genetic counselors are Master's prepared individuals who work with couples to understand the concerns associated with the occurrence, or the chance of occurrence, of a birth defect in a family. Genetic counselors help you to understand the medical facts, understand how a birth defect may be carried in a family, understand how to lower the risk of birth defects in a family, and make informed decisions about your pregnancy and the possibility that your baby may have birth defects.
The MFM Division has a record of ongoing production of basic science, clinical/translational and epidemiologic research, including membership in the Consortium on Safe Labor, Obstetric-Fetal Pharmacology Research Units Network and Nulliparous Network of the NICHD. In addition, we have long-standing partnerships with the prestigious Regenstrief Institute for informatics and healthcare research in Indianapolis
The Division supports a Perinatal Epigenetics Research Laboratory that conducts cutting-edge translational reserach in gene-environment interations that affect fetal development, maternal health and postnatal health trajectories. The Lab supports the research training of residents and fellows and collaborations with other campus investigators including those in the Wells Pediatric Research Center and IU Simon Cancer Center.
Another important component of the Division is the Pregmed (www.pregmed.org) program in pharmacogenomics. Supported by NIH funding, the focus of this work is individualized therapy for pregnant women and children. Pregmed also sponsors the annual Inernational Conference for Individualized Pharmacotherapy in Pregnancy.
The division participates fully in the education of the 40 OB/GYN residents and 280 medical students of the IU School of Medicine. The MFM physicians interact directly with residents through a specific hish risk rotation. Residents learn to care for women with complicated and high risk pregnancies in both the outpatient consultative clinic and on Labor and Delivery suites at several hospitals.
The Maternal Fetal Medicine Division is actively involved in each of the Department of Obstetrics and Gynecology's clinical, research and educational missions, striving to bring evidenced-based, compassionate, quality care to the women of Indiana.